U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > NIH Global Health Funding News - Week of March 28, 2016 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

NIH Global Health Funding News - Week of March 28, 2016

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH Funding News

Important news from NIH for all grantees.

Funding Opportunities

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

  • Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co-Infections (R01) (RFA-DE-17-006)
    Application Receipt Date(s): July 25, 2016
  • Population Health Interventions: Integrating Individual and Group Level Evidence (R01) (PA-16-146) and (R21) (PA-16-147)
    Application Receipt/Submission Date(s): Standard dates apply
  • Development of Animal Models and Related Biological Materials for Research (R21) (PA-16-141)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.
  • Using the NIMH Research Domain Criteria (RDoC) Approach to Understand Psychosis (R21) (PAR-16-135) and (R01) (PAR-16-136)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.
  • The Early Detection Research Network: Biomarker Developmental Laboratories (U01) (RFA-CA-16-009)
    Application Receipt Date(s): May 23, 2016
    Related notice: Pre-application Teleconference (NOT-CA-16-031)
  • Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01) (PA-16-144) and (R21) (PA-16-145)
    Application Receipt/Submission Date(s): Standard dates apply
  • Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R21) (PAR-16-153)
    Application Receipt/Submission Date(s): Multiple dates, see announcement.
  • Integrating Supersaturation-precipitation Mechanisms in Mechanistic Oral Absorption Models for Predicting In-vivo Performance of Associated Formulations (U01) (RFA-FD-16-025)
    Application Receipt Date(s): June 03, 2016
  • Bioequivalence of Topical Products: Comparing Dermal Pharmacokinetics by Microdialysis or Microperfusion Techniques (U01) (RFA-FD-16-028)
    Application Receipt Date(s): June 03, 2016

Funding News

NIH funding news that may be relevant to global health researchers.

  • Notice of Participation of the Office of Research Infrastructure Programs in PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)" (NOT-OD-16-077)
  • Request for Information (RFI): Building a Set of Recommended Tasks and Measures for the RDoC Matrix (NOT-MH-16-007)
  • AHRQ Announces Interest in Research that Uses Shared Decision Making as a Tool to Improve the Quality of Care for Low Income and Racial and Ethnic Minority Patients (NOT-HS-16-010)
  • NIH and FDA Request for Public Comment on Draft Clinical Trial Protocol Template for Phase 2 and 3 IND/IDE Studies (NOT-OD-16-043)
  • Notice to Extend the Application Due Date and Provide Frequently Asked Questions (FAQs) for Assessing Human Placental Development and Function Using Existing Data (R01) (NOT-HD-16-006) and (R21) (NOT-HD-16-007)
  • Notice of Change to the Specific Areas of Research Interest for Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) (NOT-DA-16-014), (R03) (NOT-DA-16-016), and (R21) (NOT-DA-16-017)
  • Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Sequencing Evidence-generating Research (CSER2): Clinical Sites (UM1) (NOT-HG-16-013), Clinical Sites with Enhanced Diversity (UM1) (NOT-HG-16-014) and Coordinating Center (U24) (NOT-HG-16-015)

Upcoming Deadlines